Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Jun 23, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-073886.pdf
0001104659-22-073886.rtf
0001104659-22-073886.xls
Jun 21, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-072944.pdf
0001104659-22-072944.rtf
0001104659-22-072944.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-071868.pdf
0001104659-22-071868.rtf
0001104659-22-071868.xls
Jun 06, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-068283.pdf
0001104659-22-068283.rtf
0001104659-22-068283.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 03, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-067864.pdf
0001104659-22-067864.rtf
0001104659-22-067864.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 02, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-067608.pdf
0001104659-22-067608.rtf
0001104659-22-067608.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065916.pdf
0001104659-22-065916.rtf
0001104659-22-065916.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065911.pdf
0001104659-22-065911.rtf
0001104659-22-065911.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065913.pdf
0001104659-22-065913.rtf
0001104659-22-065913.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065906.pdf
0001104659-22-065906.rtf
0001104659-22-065906.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.